Royal Bank of Canada Buys 51,619 Shares of Invesco Pharmaceuticals ETF $PJP

Royal Bank of Canada raised its stake in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 479.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 62,377 shares of the company’s stock after purchasing an additional 51,619 shares during the period. Royal Bank of Canada owned 1.91% of Invesco Pharmaceuticals ETF worth $6,472,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in PJP. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Invesco Pharmaceuticals ETF by 829.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 25,941 shares of the company’s stock valued at $2,712,000 after buying an additional 23,150 shares in the last quarter. Wells Fargo & Company MN lifted its position in Invesco Pharmaceuticals ETF by 96.8% during the fourth quarter. Wells Fargo & Company MN now owns 37,772 shares of the company’s stock valued at $3,949,000 after acquiring an additional 18,576 shares during the last quarter. Cetera Investment Advisers lifted its position in Invesco Pharmaceuticals ETF by 250.7% during the first quarter. Cetera Investment Advisers now owns 20,462 shares of the company’s stock valued at $2,123,000 after acquiring an additional 14,628 shares during the last quarter. BNP Paribas Financial Markets acquired a new stake in Invesco Pharmaceuticals ETF in the second quarter valued at approximately $799,000. Finally, Ameriprise Financial Inc. boosted its stake in Invesco Pharmaceuticals ETF by 214.4% in the third quarter. Ameriprise Financial Inc. now owns 12,236 shares of the company’s stock valued at $1,114,000 after acquiring an additional 8,344 shares in the last quarter.

Invesco Pharmaceuticals ETF Trading Down 0.6%

NYSEARCA PJP opened at $124.74 on Wednesday. The firm’s fifty day simple moving average is $117.82 and its two-hundred day simple moving average is $110.12. The firm has a market capitalization of $479.00 million, a P/E ratio of 15.59 and a beta of 0.45. Invesco Pharmaceuticals ETF has a 12-month low of $86.81 and a 12-month high of $125.97.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.